38694 Federal Register / Vol. 83, No. 152 / Tuesday, August 7, 2018 / Notices 

charged with the duty of winding up the 

affairs of the former institutions and 

liquidating all related assets. The 

Receiver has fulfilled its obligations and 

made all dividend distributions 

required by law. 

NOTICE OF TERMINATION OF RECEIVERSHIPS

Fund Receivership name City State Termination 

date 

10035 ................................................. Alliance Bank ..................................... Culver City ......................................... CA 8/1/2018 

10225 ................................................. BC National Banks ............................ Butler ................................................. MO 8/1/2018 

10285 ................................................. Sonoma Valley Bank ......................... Sonoma ............................................. CA 8/1/2018 

10460 ................................................. Excel Bank ......................................... Sedalia ............................................... MO 8/1/2018 

10482 ................................................. 1st Commerce Bank .......................... North Las Vegas ................................ NV 8/1/2018 

The Receiver has further irrevocably 

authorized and appointed FDICCorporate as its attorney-in-fact to 

execute and file any and all documents 

that may be required to be executed by 

the Receiver which FDIC-Corporate, in 

its sole discretion, deems necessary, 

including but not limited to releases, 

discharges, satisfactions, endorsements, 

assignments, and deeds. Effective on the 

termination dates listed above, the 

Receiverships have been terminated, the 

Receiver has been discharged, and the 

Receiverships have ceased to exist as 

legal entities. 

Dated at Washington, DC, on August 2, 

2018. 

Federal Deposit Insurance Corporation. 

Robert E. Feldman, 

Executive Secretary. 

[FR Doc. 2018–16832 Filed 8–6–18; 8:45 am] 

BILLING CODE 6714–01–P 

FEDERAL RESERVE SYSTEM 

Formations of, Acquisitions by, and 

Mergers of Bank Holding Companies 

The companies listed in this notice 

have applied to the Board for approval, 

pursuant to the Bank Holding Company 

Act of 1956 (12 U.S.C. 1841 et seq.) 

(BHC Act), Regulation Y (12 CFR part 

225), and all other applicable statutes 

and regulations to become a bank 

holding company and/or to acquire the 

assets or the ownership of, control of, or 

the power to vote shares of a bank or 

bank holding company and all of the 

banks and nonbanking companies 

owned by the bank holding company, 

including the companies listed below. 

The applications listed below, as well 

as other related filings required by the 

Board, are available for immediate 

inspection at the Federal Reserve Bank 

indicated. The applications will also be 

available for inspection at the offices of 

the Board of Governors. Interested 

persons may express their views in 

writing on the standards enumerated in 

the BHC Act (12 U.S.C. 1842(c)). If the 

proposal also involves the acquisition of 

a nonbanking company, the review also 

includes whether the acquisition of the 

nonbanking company complies with the 

standards in section 4 of the BHC Act 

(12 U.S.C. 1843). Unless otherwise 

noted, nonbanking activities will be 

conducted throughout the United States. 

Unless otherwise noted, comments 

regarding each of these applications 

must be received at the Reserve Bank 

indicated or the offices of the Board of 

Governors not later than September 4, 

2018. 

A. Federal Reserve Bank of Chicago 

(Colette A. Fried, Assistant Vice 

President) 230 South LaSalle Street, 

Chicago, Illinois 60690–1414: 

1. First Mid-Illinois Bancshares, Inc., 

Mattoon, Illinois; to acquire 100 percent 

of SCB Bancorp, Inc., and thereby 

indirectly acquire Soy Capital Bank and 

Trust Company, both of Decatur, 

Illinois. 

B. Federal Reserve Bank of 

Minneapolis (Mark A. Rauzi, Vice 

President), 90 Hennepin Avenue, 

Minneapolis, Minnesota 55480–0291: 

1. Park Financial Group, Inc., 

Minneapolis, Minnesota; to acquire 

48.46 percent of Mesaba Bancshares, 

Inc., Grand Rapids, Minnesota; and 

thereby indirectly acquire The Lake 

Bank, Two Harbors, Minnesota, and 

American Bank of the North, Nashwauk, 

Minnesota. In addition, Park Financial 

Group, Inc., has acquired an option to 

purchase the remaining 51.54 percent of 

the voting shares of Mesaba Bancshares, 

Inc., Grand Rapids, Minnesota. 

Board of Governors of the Federal Reserve 

System, August 2, 2018. 

Yao-Chin Chao, 

Assistant Secretary of the Board. 

[FR Doc. 2018–16872 Filed 8–6–18; 8:45 am] 

BILLING CODE 6210–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30Day–18–17BAN] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

In accordance with the Paperwork 

Reduction Act of 1995, the Centers for 

Disease Control and Prevention (CDC) 

has submitted the information 

collection request entitled 

Strengthening United States Response to 

Resistant Gonorrhea (SURRG) to the 

Office of Management and Budget 

(OMB) for review and approval. CDC 

previously published a ‘‘Proposed Data 

Collection Submitted for Public 

Comment and Recommendations’’ 

notice on November 15, 2017 to obtain 

comments from the public and affected 

agencies. CDC received one nonsubstantive comment on this 60 day 

public notice. This notice serves to 

allow an additional 30 days for public 

and affected agency comments. 

CDC will accept all comments for this 

proposed information collection project. 

The Office of Management and Budget 

is particularly interested in comments 

that: 

(a) Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

(b) Evaluate the accuracy of the 

agencies estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

(c) Enhance the quality, utility, and 

clarity of the information to be 

collected; 

(d) Minimize the burden of the 

collection of information on those who 

are to respond, including, through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 


daltland on DSKBBV9HB2PROD with NOTICES
Federal Register / Vol. 83, No. 152 / Tuesday, August 7, 2018 / Notices 38695 

e.g., permitting electronic submission of 

responses; and 

(e) Assess information collection 

costs. 

To request additional information on 

the proposed project or to obtain a copy 

of the information collection plan and 

instruments, call (404) 639–7570 or 

send an email to omb@cdc.gov. Direct 

written comments and/or suggestions 

regarding the items contained in this 

notice to the Attention: CDC Desk 

Officer, Office of Management and 

Budget, 725 17th Street NW, 

Washington, DC 20503 or by fax to (202) 

395–5806. Provide written comments 

within 30 days of notice publication. 

Proposed Project 

Strengthening U.S. Response to 

Resistant Gonorrhea (SURRG)—New— 

National Center for HIV/AIDS, Viral 

Hepatitis, STD, and TB Prevention 

(NCHHSTP), Centers for Disease Control 

and Prevention (CDC). 

Background and Brief Description 

The purposes of Strengthening U.S. 

Response to Resistant Gonorrhea 

(SURRG) are to: (1) Improve national 

capacity to detect, monitor, and respond 

to emerging antibiotic-resistant 

gonorrhea, (2) understand trends in, and 

factors contributing to antibioticresistant gonorrhea, and (3) build a 

robust evidence base for public health 

action. This information collection is 

important because: (1) Effective 

treatment of gonorrhea is critical to 

gonorrhea control and prevention; (2) 

untreated or inadequately treated 

gonorrhea can cause serious 

reproductive health complications, such 

as infertility; (3) Neisseria gonorrhoeae 

(the bacterium that causes gonorrhea) 

has consistently demonstrated the 

ability to develop resistance to the 

antibiotics used for treatment and may 

be developing resistance to the last 

remaining treatment option 

recommended by the CDC; and (4) 

antibiotic-resistant gonorrhea is 

extremely difficult to detect without 

enhanced surveillance and public 

health activities, such as SURRG, 

because healthcare providers rarely 

perform or have access to resistance 

testing for individual patients. 

SURRG will support rapid detection 

of resistant gonorrhea and get actionable 

information into the hands of healthcare 

providers (to support appropriate 

treatment of individual patients) and 

local health departments (to support 

rapid public health response to slow the 

spread of resistant infections). 

Jurisdictions participating in SURRG 

applied, as part of a competitive 

process, and will participate 

voluntarily. As an overview of SURRG, 

healthcare providers at participating 

clinics (sexually transmitted disease 

[STD] clinics affiliated with a single 

public health department or other 

participating non-STD clinic sites) will 

collect specimens for N. gonorrhoeae 

culture testing from men and women 

seeking care for possible gonorrhea. 

Specimens that demonstrate N. 

gonorrhoeae (called ‘‘isolates’’) will 

undergo antibiotic resistance testing 

within several days at the local public 

health laboratory. Laboratory results 

demonstrating resistance will be rapidly 

communicated by the laboratory to the 

healthcare provider and designated 

health department staff member, who 

will initiate a field investigation. 

Researchers will interview the patient 

(from whom the resistant specimen was 

collected) about risk factors and recent 

contacts, and will re-test to ensure cure. 

The health department will interview 

recent contacts and test them for 

gonorrhea. The participating health 

departments will collect and transmit to 

CDC, demographic and clinical data 

about persons tested for and diagnosed 

with gonorrhea in the participating 

clinics, results of local antibiotic 

resistance testing, and information 

about field investigations. None of the 

data transmitted to CDC will contain 

any personally identifiable information. 

CDC will use the data to monitor 

resistance, understand risk factors for 

resistance, and identify new approaches 

to prevent the spread of resistance. CDC 

will receive transmitted data through its 

Secure Access Management Services 

(SAMS). SAMS is an approved federal 

information technology system that 

provides authorized and validated users 

secure and encrypted access to CDC file 

transfer applications. The encrypted 

data will be stored in a secure CDC 

server with strictly controlled and 

restricted access rights. Isolates will be 

shipped each month to one of four 

Antibiotic Resistance Regional 

Laboratory Network (ARLN) laboratories 

for confirmatory antibiotic susceptibility 

testing and molecular characterization. 

Under the SURRG protocol, the local 

SURRG data managers from each of the 

funded jurisdictions will abstract STD 

clinic data for patients tested for 

gonorrhea, receive data from non-STD 

clinic healthcare sites about persons 

tested for gonorrhea, receive resistance 

testing laboratory results from local 

public health laboratories, abstract data 

about field investigations, and will 

merge the data. Every two months, the 

local SURRG data manager will clean 

the data, remove personally identifiable 

information, and transmit the data to 

CDC. We estimate these data processes 

will take 16 hours every two months. 

Annually, the local SURRG data 

manager will send a final cumulative 

data file. Seven data transmissions/ 

responses will occur. 

Every two months, data managers at 

each of the participating non-STD clinic 

health centers will abstract and clean 

data and securely transmit the data to 

the local SURRG data manager. We 

estimate that it will take 3 hours each 

time data managers at each non-STD 

SURRG location abstract, clean, and 

transmit SURRG data. 

Microbiologists at public health 

laboratories from each of the nine 

SURRG funded jurisdictions will 

conduct antibiotic resistance testing on 

all N. gonorrhoeae isolates from all STD 

clinic sites and non-STD clinic sites 

participating in SURRG. Each test takes 

approximately 10 minutes of staff time, 

and testing of control strains will also be 

conducted approximately twice per 

week at each laboratory. On average, 

each jurisdiction will conduct 

approximately 600 resistance tests per 

year for patient care, plus 100 control 

strains per year for quality assurance. 

Thus, each grantee will perform 

approximately 700 tests per year. Every 

two months, a laboratory data manager 

will abstract test results and securely 

send the data file to the local SURRG 

data manager. We estimate that 

laboratory data managers will spend 

approximately 1 hour each time they 

abstract, clean, and transmit project 

data. 

Health department staff will interview 

any person diagnosed with antibioticresistant gonorrhea or having a case of 

gonorrhea of public health significance 

index case, a diagnosed person’s social 

and sexual contacts, and the sexual 

contacts of the index case’s sexual 

contacts. 

On average, each jurisdiction will 

identify four drug-resistant isolates each 

month. These isolates will spur field 

investigations, which will result in six 

additional interviews each month. We 

estimate 120 interviews will occur 

annually at each site (annual 1,080 

interviews for the nine sites). Each 

interview will take 30 minutes. 

The total estimated annual burden 

hours are 2,976. Respondents receive 

federal funds to participate in this 

project. There are no additional costs to 

respondents other than their time. 


daltland on DSKBBV9HB2PROD with NOTICES
38696 Federal Register / Vol. 83, No. 152 / Tuesday, August 7, 2018 / Notices 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Local SURRG data manager .......................... Facility, Laboratory and field Elements .......... 9 7 16 

Data manager at non-STD clinic health centers.Non-STD clinic Elements ............................... 18 6 3 

Public Health Laboratory Microbiologist ......... Laboratory Testing ......................................... 9 700 10/60 

Public Health Laboratory Data Manager ........ Laboratory Elements ...................................... 9 6 1 

Gonorrhea Patients, Social and Sexual Contacts.Field Investigation Elements .......................... 1,080 1 30/60 

Jeffrey M. Zirger, 

Acting Chief, Information Collection Review 

Office, Office of Scientific Integrity, Office 

of the Associate Director for Science, Office 

of the Director, Centers for Disease Control 

and Prevention. 

[FR Doc. 2018–16797 Filed 8–6–18; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

Privacy Act of 1974; Matching Program 

AGENCY: Centers for Medicare & 

Medicaid Services, Department of 

Health and Human Services. 

ACTION: Notice of a new matching 

program. 

SUMMARY: In accordance with the 

Privacy Act of 1974, as amended, the 

Department of Health and Human 

Services (HHS), Centers for Medicare & 

Medicaid Services (CMS) is providing 

notice of a re-established matching 

program between CMS and the Social 

Security Administration (SSA), 

‘‘Determining Enrollment or Eligibility 

for Insurance Affordability Programs 

Under the Patient Protection and 

Affordable Care Act (ACA).’’ The 

matching program provides CMS with 

SSA data to use in determining 

individuals’ eligibility to enroll in a 

qualified health plan through an 

exchange established under the ACA 

and for insurance affordability programs 

and certificates of exemption, and to 

make eligibility redeterminations and 

renewals, including appeal 

determinations. 

DATES: The deadline for comments on 

this notice is September 6, 2018. The reestablished matching program will 

commence not sooner than 30 days after 

publication of this notice, provided no 

comments are received that warrant a 

change to this notice. The matching 

program will be conducted for an initial 

term of 18 months (from approximately 

September 2018 to March 2020) and 

within 3 months of expiration may be 

renewed for one additional year if the 

parties make no change to the matching 

program and certify that the program 

has been conducted in compliance with 

the matching agreement. 

ADDRESSES: Interested parties may 

submit written comments on this notice, 

by mail or email, to the CMS Privacy 

Officer, Division of Security, Privacy 

Policy & Governance, Information 

Security & Privacy Group, Office of 

Information Technology, Centers for 

Medicare & Medicaid Services, 

Location: N1–14–56, 7500 Security 

Blvd., Baltimore, MD 21244–1850, 

Walter.Stone@cms.hhs.gov. 

FOR FURTHER INFORMATION CONTACT: If 

you have questions about the matching 

program, you may contact Jack Lavelle, 

Senior Advisor, Marketplace Eligibility 

and Enrollment Group, Centers for 

Consumer Information and Insurance 

Oversight, CMS, at (410) 786–0639, or 

by email at Jack.Lavelle1@cms.hhs.gov, 

or by mail at 7501 Wisconsin Ave., 

Bethesda, MD 20814. 

SUPPLEMENTARY INFORMATION: The 

Privacy Act of 1974, as amended (5 

U.S.C. 552a) provides certain 

protections for individuals applying for 

and receiving Federal benefits. The law 

governs the use of computer matching 

by Federal agencies when records in a 

system of records (meaning, federal 

agency records about individuals 

retrieved by name or other personal 

identifier) are matched with records of 

other federal or non-federal agencies. 

The Privacy Act requires agencies 

involved in a matching program to: 

1. Enter into a written agreement, 

which must be prepared in accordance 

with the Privacy Act, approved by the 

Data Integrity Board of each source and 

recipient Federal agency, provided to 

Congress and the Office of Management 

and Budget (OMB), and made available 

to the public, as required by 5 United 

States Code (U.S.C.) 552a(o), (u)(3)(A), 

and (u)(4). 

2. Notify the individuals whose 

information will be used in the 

matching program that the information 

they provide is subject to verification 

through matching, as required by 5 

U.S.C. 552a(o)(1)(D). 

3. Verify match findings before 

suspending, terminating, reducing, or 

making a final denial of an individual’s 

benefits or payments or taking other 

adverse action against the individual, as 

required by 5 U.S.C. 552a(p). 

4. Report the matching program to 

Congress and the OMB, in advance and 

annually, as required by 5 U.S.C. 

552a(o)(2)(A)(i), (r), and (u)(3)(D). 

5. Publish advance notice of the 

matching program in the Federal 

Register as required by 5 U.S.C. 

552a(e)(12). 

This matching program meets these 

requirements. 

Dated: August 1, 2018. 

Walter Stone, 

CMS Privacy Act Officer, Division of Security 

Privacy Policy and Governance, Information 

Security and Privacy Group, Office of 

Information Technology, Centers for Medicare 

& Medicaid Services. 

PARTICIPATING AGENCIES 

Department of Health and Human 

Services (HHS), Centers for Medicare & 

Medicaid Services (CMS) is the 

recipient agency, and the Social 

Security Administration (SSA) is the 

source agency. 

AUTHORITY FOR CONDUCTING THE MATCHING

PROGRAM: 

The matching program is authorized 

under 42 U.S.C. 18001. 

PURPOSE(S): 

The purpose of the matching program 

is to provide CMS with SSA data that 

CMS needs to determine individuals’ 

eligibility to enroll in a qualified health 

plan through an exchange established 

under the ACA and for insurance 

affordability programs and certificates of 

exemption, and to make eligibility 

redetermination and renewal decisions, 

including appeal determinations. The 


daltland on DSKBBV9HB2PROD with NOTICES